JP2007513877A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513877A5
JP2007513877A5 JP2006539731A JP2006539731A JP2007513877A5 JP 2007513877 A5 JP2007513877 A5 JP 2007513877A5 JP 2006539731 A JP2006539731 A JP 2006539731A JP 2006539731 A JP2006539731 A JP 2006539731A JP 2007513877 A5 JP2007513877 A5 JP 2007513877A5
Authority
JP
Japan
Prior art keywords
methyl
sulfinyl
ethene
chlorophenyl
methoxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006539731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513877A (ja
JP5196787B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/037293 external-priority patent/WO2005046599A2/en
Publication of JP2007513877A publication Critical patent/JP2007513877A/ja
Publication of JP2007513877A5 publication Critical patent/JP2007513877A5/ja
Application granted granted Critical
Publication of JP5196787B2 publication Critical patent/JP5196787B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006539731A 2003-11-14 2004-11-08 増殖性疾患を治療するためのα,β−不飽和スルホキシド Expired - Fee Related JP5196787B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52052303P 2003-11-14 2003-11-14
US60/520,523 2003-11-14
PCT/US2004/037293 WO2005046599A2 (en) 2003-11-14 2004-11-08 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders

Publications (3)

Publication Number Publication Date
JP2007513877A JP2007513877A (ja) 2007-05-31
JP2007513877A5 true JP2007513877A5 (enExample) 2007-12-27
JP5196787B2 JP5196787B2 (ja) 2013-05-15

Family

ID=34590471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006539731A Expired - Fee Related JP5196787B2 (ja) 2003-11-14 2004-11-08 増殖性疾患を治療するためのα,β−不飽和スルホキシド

Country Status (12)

Country Link
US (1) US7744889B2 (enExample)
EP (1) EP1689706B1 (enExample)
JP (1) JP5196787B2 (enExample)
KR (1) KR20060109871A (enExample)
AU (1) AU2004289281C1 (enExample)
CA (1) CA2546495C (enExample)
DK (1) DK1689706T3 (enExample)
ES (1) ES2621802T3 (enExample)
HU (1) HUE032523T2 (enExample)
IL (1) IL174426A (enExample)
NZ (1) NZ545995A (enExample)
WO (1) WO2005046599A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740530B8 (en) * 2004-03-16 2017-03-01 Temple University - Of The Commonwealth System of Higher Education Substituted phenoxy- and phenylthio-derivatives for treating proliferative disorders
EP1841420B1 (en) * 2005-01-05 2011-12-07 Temple University - Of The Commonwealth System of Higher Education Treatment of drug-resistant proliferative disorders
US8106033B2 (en) * 2005-03-11 2012-01-31 Temple University - Of The Commonwealth System Of Higher Education Composition and methods for the treatment of proliferative diseases
US20100080843A1 (en) * 2005-06-30 2010-04-01 The Research Foundation of the State University Of New York at Albany Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis
WO2010075026A2 (en) * 2008-12-16 2010-07-01 Onconova Therapeutics Inc Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human
GB201010359D0 (en) * 2010-06-21 2010-08-04 Univ Nottingham Compounds for treating proliferative disorders
EP2486923B1 (en) * 2011-02-11 2015-09-09 Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG Histone deacetylase (HDAC) inhibiting compounds and method of making same
CN110776447A (zh) 2012-09-20 2020-02-11 坦普尔大学 取代的烷基二芳基衍生物、制备方法和用途
JP2016523830A (ja) * 2013-05-07 2016-08-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 放射線緩和薬学的配合物
CN104892471B (zh) * 2015-05-15 2020-03-27 中国人民解放军军事医学科学院放射与辐射医学研究所 具有蛋白酪氨酸激酶抑制活性的物质、其制备方法及用途
US10383831B2 (en) * 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use
CN106432011B (zh) * 2016-09-18 2018-11-02 中国医学科学院放射医学研究所 一类具有辐射防护作用的新化合物、其制备方法及其药物应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865867A (en) * 1967-06-19 1975-02-11 Monsanto Co Meta-bifunctional benzenes
US3975435A (en) * 1974-03-06 1976-08-17 Givaudan Corporation Substituted cinnamanilides
GB1527109A (en) * 1974-12-28 1978-10-04 Asahi Chemical Ind Cephalosporin derivatives and process for preparing same
JPH05262733A (ja) * 1992-03-23 1993-10-12 Sapporo Breweries Ltd 含硫黄化合物,その製造法及びそれを有効成分とする抗潰瘍剤
US5523302A (en) * 1993-11-24 1996-06-04 The Du Pont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
CN1287783C (zh) * 1997-05-14 2006-12-06 阿特罗吉尼克斯公司 普罗布考单酯在制备用于治疗心血管疾病和炎性疾病的药物中的应用
CZ299718B6 (cs) * 1997-10-03 2008-10-29 Temple University - Of The Commonwealth System Ofhigher Education Styrylsulfonová sloucenina a farmaceutický prostredek ji obsahující
US6548553B2 (en) * 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
US6201154B1 (en) * 1999-03-31 2001-03-13 Temple University-Of The Commonwealth Of Higher Education Z-styryl sulfone anticancer agents
US6762207B1 (en) * 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
JP4596651B2 (ja) * 1999-04-02 2010-12-08 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション (e)−スチリルスルホン抗癌剤
AU3381399A (en) * 1999-04-02 2000-10-23 Temple University - Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
US6117364A (en) * 1999-05-27 2000-09-12 Nalco/Exxon Energy Chemicals, L.P. Acid corrosion inhibitor
WO2000077169A2 (en) * 1999-06-16 2000-12-21 Temple University - Of The Commonwealth System Of Higher Education (z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
AU780844B2 (en) * 1999-10-12 2005-04-21 Temple University-Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
US6486210B2 (en) * 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
US6541475B2 (en) * 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
WO2002028828A1 (en) * 2000-10-05 2002-04-11 Temple University - Of The Commonwealth System Of Higher Education Substituted (e)-styryl benzylsulfones for treating proliferative disorders
EP1493913B1 (en) * 2000-10-12 2005-12-28 Yamaha Hatsudoki Kabushiki Kaisha Fuel gas mixer
US6833480B2 (en) * 2001-02-27 2004-12-21 Temple University - Of The Commonwealth System Of Higher Education (Z)-styrylbenzylsulfones and pharmaceutical uses thereof
JP4302986B2 (ja) * 2001-02-28 2009-07-29 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 細胞及び組織をα,β不飽和アリールスルホンにより電離放射線から防護する方法
CA2439255C (en) * 2001-02-28 2011-01-04 Temple University Of The Commonwealth System Of Higher Education N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
MXPA04008356A (es) * 2002-02-28 2005-09-12 Univ Temple (e)-2,6-dialcoxiestiril bencilsulfonas sustituidas con un grupo amino y en la posicion 4 para tratar trastornos poliferativos.
EP1740530B8 (en) * 2004-03-16 2017-03-01 Temple University - Of The Commonwealth System of Higher Education Substituted phenoxy- and phenylthio-derivatives for treating proliferative disorders
US8106033B2 (en) * 2005-03-11 2012-01-31 Temple University - Of The Commonwealth System Of Higher Education Composition and methods for the treatment of proliferative diseases

Similar Documents

Publication Publication Date Title
JP2007513877A5 (enExample)
ES2154252T3 (es) Inhibicion de quinasa p38 utilizando difenil-ureas simetricas y asimetricas.
RU2360912C2 (ru) Замещенные дигидрохиназолины с противовирусными свойствами
JP2007502806A5 (enExample)
JP2007505877A5 (enExample)
JP2013523896A5 (enExample)
RU2502730C2 (ru) Сульфонамидные соединения и их применение
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
JP2005534635A5 (enExample)
JP2010523476A5 (enExample)
JP2014502979A5 (enExample)
RU2017121906A (ru) Конъюгаты цистеамина и жирной кислоты и их применение в качестве активаторов аутофагии
JP2004514663A5 (enExample)
JP2007509928A5 (enExample)
DK1202957T3 (da) Aminobenzofenoner som inhibitorer for IL-1beta og TNF-alfa
JP2007537286A5 (enExample)
JP2006501201A5 (enExample)
JPWO2023195529A5 (enExample)
RU2016104844A (ru) Производные n-мочевино замещенных аминокислот как модуляторы формил-пептидного рецептора
RU2016134130A (ru) ПИРАЗОЛО[1,5-а]ПИРИМИДИНЫ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ СОЕДИНЕНИЙ
RU2389719C3 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
CA2546495A1 (en) Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
JP2007515467A5 (enExample)
JP2005522492A5 (enExample)
JP2006516626A5 (enExample)